Search results (61)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. | Academic Article |
Why?
|
Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. | Academic Article |
Why?
|
Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus. | Academic Article |
Why?
|
Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. | Academic Article |
Why?
|
Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. | Academic Article |
Why?
|
Macrophage activation syndrome in the acute phase of Kawasaki disease. | Academic Article |
Why?
|
Macrophage activation syndrome--what's in a name! | Academic Article |
Why?
|
Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? | Academic Article |
Why?
|
Predicting macrophage activation syndrome (MAS) in childhood-onsetsystemic lupus erythematosus (cSLE) patients at diagnosis. | Academic Article |
Why?
|
Macrophage Activation | Concept |
Why?
|
Macrophage Activation Syndrome | Concept |
Why?
|
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Academic Article |
Why?
|
Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis. | Academic Article |
Why?
|
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Academic Article |
Why?
|
Schneider, Rayfel | Person |
Why?
|